Get Help Sign In

IDT acquires Archer™ next generation sequencing (NGS) assays

Enabling researchers to advance actionable scientific discoveries

Frequently asked questions

Ordering & Invoicing

Product Support and Manufacturing

Shipping and Returns

Educational Materials

Demaris Mills
Integrated DNA Technologies

The acquisition of Archer™ NGS research assays strategically lays the foundation for IDT to become a leading oncology research solutions provider and aligns with our business focus of accelerating the road to scientific discovery. Our 35-year history of delivering innovative technologies that enable the greatest genomic breakthroughs uniquely position us to accelerate our NGS platform for the betterment of humankind.

Icons Library_Ocean_85x85_FAQs

Questions? We’ll help.

Contact us

Get up to date. Stay up to date.

Sign up to receive IDT communications about product updates, upcoming events, and other relevant content.


*RUO—For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.